Developer docs
API playgroundTry for free, no card

Search company profiles

I AM ALS.

Full company profile

uuid000btgo

Namestring
I AM ALS.
Legal namestring
I AM ALS
Websiteurl
iamals.org
Company typeenum
Private
Founded yearint
2019
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersWashington, United States
HQ citystring
Washington
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
ALS patient advocacy, peer support services, clinical trial resources, federal research funding, caregiver support programs
Industry1 code
PRIMARYBPAGACAA
Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS)
NAICS code1 code
  • Business, Professional, Labor, Political, and Similar Organizations8139
SIC code1 code
  • Services-Membership Organizations8600
Product category
Nonprofit Patient Advocacy and ALS Support Services
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model5 records
1Individual Donations
TypeGrants Donations
Description

One-time and recurring donations from individual supporters; monthly recurring gift program available with flexible amounts

iamals.org
2Peer-to-Peer Fundraising
TypeGrants Donations
Description

Community members can create personal fundraising pages through DonorDrive platform to raise funds on behalf of I AM ALS

iamals.org
3Employer Matching
TypeAffiliate Referral
Description

Many employers match employee donations; platform provided to check eligibility and access forms

iamals.org
4Stock and Cryptocurrency Donations
TypeGrants Donations
Description

Donors can give appreciated assets like stock or cryptocurrency, avoiding capital gains tax and receiving full fair market value deduction

iamals.org
5Foundation and Corporate Grants
TypeGrants Donations
Description

Revenue from generous donors, foundation funders, and industry partners including a $2M reserve from 2024 Yield Giving grant

iamals.org
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Others
Pricing details1 tier
1Free Support Services
ModelFreemiumBilling cadenceOthers
Notes

All support services including peer mentoring, support groups, ALS Support Specialist consultations, and resources are provided free to patients and families regardless of financial situation

iamals.org
GTM typeB2C
B2C
Offering typeServices
Services
Brand1 record
1Cures Collective
Description

A coalition launched by I AM ALS in April 2024 to unify neurodegenerative diseases, accelerate the path to treatments, and improve access to care through collaboration. Represents more than 50 organizations across ALS, Parkinson's, Frontotemporal dementia, Huntington's, Alzheimer's, Multiple Sclerosis, and more.

iamals.org
Core offering1 text field

I AM ALS is a patient-led nonprofit organization that provides free, personalized support services to people living with ALS, caregivers, veterans, and bereaved families — including one-on-one ALS Support Specialists, peer mentorship, virtual support groups, and educational programs. It also runs federal advocacy campaigns (Push for Progress and ACT for ALS reauthorization) to expand research funding and treatment access, and coordinates the Cures Collective coalition of 50+ neurodegenerative disease organizations.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • $1.6 billion in total federal funding secured since 2019
+3 more records
Product overview1 text field

I AM ALS is a patient-led nonprofit organization operating as a community-driven movement rather than a traditional product company. The organization offers a coordinated suite of support services including personalized ALS Support Specialists, Peer Mentor and Peer Support Specialist Programs, virtual support groups categorized by audience (people with ALS, caregivers, veterans, those who have lost loved ones), an online resource center, and the Ask Me Anything ALS educational series. These services are complemented byALS Signal (a clinical research dashboard), veterans-specific resources, and community-building initiatives like the Cures Collective coalition. The organization also runs advocacy campaigns including Push for Progress (federal funding) and ACT for ALS reauthorization efforts, and maintains a donation/fundraising platform supporting multiple giving methods. Technology integrations include Zoom (support groups), SurveyMonkey (applications), EveryAction (donations), DonorDrive (peer-to-peer fundraising), Double the Donation (employer matching), PayPal, and FastAction/NGPVAN (advocacy actions).

Product and service1 record
1ALS Support Services
Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership13 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-04-01
Description

Steering committee member of Cures Collective, bringing expertise in caregiving and ALS patient support

2Huntington's Disease Youth Organization
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-04-01
Description

Steering committee member representing youth and family perspectives in Huntington's disease within Cures Collective

iamals.org
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-04-01
Description

Steering committee member bringing ALS patient support expertise to Cures Collective

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-04-01
Description

Parkinson's disease advocacy group serving on Cures Collective steering committee

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-04-01
Description

Coalition for GRIN disorders represented on Cures Collective steering committee

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-04-01
Description

Pediatric neurodegenerative disease advocacy organization on Cures Collective steering committee

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-04-01
Description

Member organization of Cures Collective representing largest ALS advocacy organization

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-04-01
Description

Member organization of Cures Collective bringing Parkinson's disease research advocacy

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-04-01
Description

Member organization representing multiple sclerosis community in Cures Collective

10Eric Dane
Strategic tierCoreTypeGTM or Marketing PartnerAnnounced on2024-04-01
Description

Actor and I AM ALS ambassador starring in "Ring Every Bell" documentary; raises awareness through celebrity platform

iamals.org
11Brian Wallach
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-04-01
Description

Co-founder of I AM ALS, diagnosed with ALS in 2019; leads patient advocacy movement

iamals.org
Strategic tierCoreTypeImplementation/ SI/ Consulting PartnerAnnounced on2024-04-01
Description

Helps veterans with ALS navigate VA benefits; PVA representatives expedite approval process for disability claims

13ACT for ALS Coalition
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2021-01-01
Description

Landmark legislation passed with bipartisan support providing $500M over five years for ALS research and Expanded Access Programs

iamals.org
Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Umbrella advocacy organization for rare diseases including ALS. Comparable federal advocacy and patient support posture, but with broader disease portfolio and longer operating history.

TypeBroad incumbent
Description

Largest ALS-focused nonprofit in the U.S., funding research, advocacy, and care services through 39 chapters. Directly comparable as a disease-specific advocacy and support organization for ALS, but with substantially larger budget and clinical infrastructure.

TypeDirect peer
Description

Largest patient-led Parkinson's research and advocacy funder, known for aggressive federal funding advocacy. The most directly analogous patient-led movement model for a neurodegenerative disease, and a Cures Collective member.

TypeEmerging player
Description

ALS-focused nonprofit funding collaborative research and translational drug development. Comparable disease-specific research funding focus, but more narrowly oriented to academic-industry collaboration.

TypeDirect peer
Description

Disease-specific nonprofit funding research and public education across Alzheimer's, macular degeneration, and glaucoma. Cures Collective sponsor with comparable disease-specific grant-making and advocacy posture.

TypeEmerging player
Description

Rare disease policy advocacy organization focused on accelerating FDA review of therapies. Comparable federal legislative advocacy orientation for underserved disease populations, including ALS-relevant policy work.

TypeDirect peer
Description

ALS-focused research initiative providing patient-derived data and bio samples to researchers. Comparable ALS-specific mission with emphasis on accelerating precision medicine and clinical research infrastructure.

TypeBroad incumbent
Description

Large disease-specific nonprofit supporting research and care across neuromuscular diseases including ALS. Comparable patient services, advocacy, and research funding model, but with broader disease portfolio.

TypeDirect peer
Description

Boston-based biotech nonprofit dedicated to ALS drug discovery and preclinical research. Comparable ALS-specific mission with research funding focus, but distinct drug-development orientation.

TypeDirect peer
Description

Chicago-based ALS nonprofit providing support services, research funding, and advocacy since 1977. A Cures Collective steering committee member with overlapping patient support and ALS advocacy mission.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration7 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles23 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

I AM ALS.

Nonprofit Patient Advocacy and ALS Support Servicesiamals.org

I AM ALS. firmographics

Firmographics
Name
I AM ALS.
Legal name
I AM ALS
Website
https://iamals.org
Company type
Private
Founded year
2019
Operating status
Operating
Headcount range
51–100 employees
Ownership category
akta.pro rank

I AM ALS. industry classification

Industry
Product category
Nonprofit Patient Advocacy and ALS Support Services
NAICS
Business, Professional, Labor, Political, and Similar Organizations (8139)
SIC
Services-Membership Organizations (8600)
akta.pro industry
PRIMARYBPAGACAA
Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS)

Keywords

  • ALS patient advocacy
  • Peer support services
  • Clinical trial resources
  • Federal research funding
  • Caregiver support programs

Where I AM ALS. is headquartered

Location

Headquarters

HQ city
Washington
HQ country
United States
HQ region
North America

Offices1 record

Markets served

I AM ALS. business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

  1. Individual Donations: One-time and recurring donations from individual supporters; monthly recurring gift program available with flexible amounts
  2. Peer-to-Peer Fundraising: Community members can create personal fundraising pages through DonorDrive platform to raise funds on behalf of I AM ALS
  3. Employer Matching: Many employers match employee donations; platform provided to check eligibility and access forms
  4. Stock and Cryptocurrency Donations: Donors can give appreciated assets like stock or cryptocurrency, avoiding capital gains tax and receiving full fair market value deduction
  5. Foundation and Corporate Grants: Revenue from generous donors, foundation funders, and industry partners including a $2M reserve from 2024 Yield Giving grant

Pricing tiers

ModelBillingPrice
FreemiumOthersFree Support Services

Go-to-market motion3 records

Distribution channels5 records

Marketing channels8 records

I AM ALS. product offering

Product offering

Core offering

I AM ALS is a patient-led nonprofit organization that provides free, personalized support services to people living with ALS, caregivers, veterans, and bereaved families — including one-on-one ALS Support Specialists, peer mentorship, virtual support groups, and educational programs. It also runs federal advocacy campaigns (Push for Progress and ACT for ALS reauthorization) to expand research funding and treatment access, and coordinates the Cures Collective coalition of 50+ neurodegenerative disease organizations.

Product overview

I AM ALS is a patient-led nonprofit organization operating as a community-driven movement rather than a traditional product company. The organization offers a coordinated suite of support services including personalized ALS Support Specialists, Peer Mentor and Peer Support Specialist Programs, virtual support groups categorized by audience (people with ALS, caregivers, veterans, those who have lost loved ones), an online resource center, and the Ask Me Anything ALS educational series. These services are complemented byALS Signal (a clinical research dashboard), veterans-specific resources, and community-building initiatives like the Cures Collective coalition. The organization also runs advocacy campaigns including Push for Progress (federal funding) and ACT for ALS reauthorization efforts, and maintains a donation/fundraising platform supporting multiple giving methods. Technology integrations include Zoom (support groups), SurveyMonkey (applications), EveryAction (donations), DonorDrive (peer-to-peer fundraising), Double the Donation (employer matching), PayPal, and FastAction/NGPVAN (advocacy actions).

Differentiator

Problem solved

Functional benefit

Brands

  • Cures Collective: A coalition launched by I AM ALS in April 2024 to unify neurodegenerative diseases, accelerate the path to treatments, and improve access to care through collaboration. Represents more than 50 organizations across ALS, Parkinson's, Frontotemporal dementia, Huntington's, Alzheimer's, Multiple Sclerosis, and more.

Products and services

  • ALS Support Services

Quantifiable outcome

  • $1.6 billion in total federal funding secured since 2019
  • +3 more outcomes

Companies that use I AM ALS.

Customer profile

Named customers5 records

Segments5 records

Ideal customer profiles4 records

I AM ALS. technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration7 records

Feature4 records

I AM ALS. partnerships and signals

Strategic signal

Partnerships

13 partnerships are on record, tiered core.

  • Hummingbird FundcoreStrategic or Co-development Partner · 1 April 2024Steering committee member of Cures Collective, bringing expertise in caregiving and ALS patient support
  • Huntington's Disease Youth OrganizationcoreStrategic or Co-development Partner · 1 April 2024Steering committee member representing youth and family perspectives in Huntington's disease within Cures Collective
  • Les Turner ALS FoundationcoreStrategic or Co-development Partner · 1 April 2024Steering committee member bringing ALS patient support expertise to Cures Collective
  • PD AvengerscoreStrategic or Co-development Partner · 1 April 2024Parkinson's disease advocacy group serving on Cures Collective steering committee
  • CureGRNcoreStrategic or Co-development Partner · 1 April 2024Coalition for GRIN disorders represented on Cures Collective steering committee
  • Hop On A CurecoreStrategic or Co-development Partner · 1 April 2024Pediatric neurodegenerative disease advocacy organization on Cures Collective steering committee
  • ALS AssociationcoreStrategic or Co-development Partner · 1 April 2024Member organization of Cures Collective representing largest ALS advocacy organization
  • Michael J. Fox FoundationcoreStrategic or Co-development Partner · 1 April 2024Member organization of Cures Collective bringing Parkinson's disease research advocacy
  • National MS SocietycoreStrategic or Co-development Partner · 1 April 2024Member organization representing multiple sclerosis community in Cures Collective
  • Eric DanecoreGTM or Marketing Partner · 1 April 2024Actor and I AM ALS ambassador starring in "Ring Every Bell" documentary; raises awareness through celebrity platform
  • Brian WallachcoreStrategic or Co-development Partner · 1 April 2024Co-founder of I AM ALS, diagnosed with ALS in 2019; leads patient advocacy movement
  • Paralyzed Veterans of AmericacoreImplementation/ SI/ Consulting Partner · 1 April 2024Helps veterans with ALS navigate VA benefits; PVA representatives expedite approval process for disability claims
  • ACT for ALS CoalitioncoreStrategic or Co-development Partner · 1 January 2021Landmark legislation passed with bipartisan support providing $500M over five years for ALS research and Expanded Access Programs

Scale indicators7 records

Recent moves7 records

Expansion highlights6 records

I AM ALS. competitors and assessment

Company assessment

Broad incumbents

  • National Organization for Rare Disorders (NORD): Umbrella advocacy organization for rare diseases including ALS. Comparable federal advocacy and patient support posture, but with broader disease portfolio and longer operating history.
  • ALS Association: Largest ALS-focused nonprofit in the U.S., funding research, advocacy, and care services through 39 chapters. Directly comparable as a disease-specific advocacy and support organization for ALS, but with substantially larger budget and clinical infrastructure.
  • Muscular Dystrophy Association (MDA): Large disease-specific nonprofit supporting research and care across neuromuscular diseases including ALS. Comparable patient services, advocacy, and research funding model, but with broader disease portfolio.

Direct peers

  • Michael J. Fox Foundation for Parkinson's Research: Largest patient-led Parkinson's research and advocacy funder, known for aggressive federal funding advocacy. The most directly analogous patient-led movement model for a neurodegenerative disease, and a Cures Collective member.
  • BrightFocus Foundation: Disease-specific nonprofit funding research and public education across Alzheimer's, macular degeneration, and glaucoma. Cures Collective sponsor with comparable disease-specific grant-making and advocacy posture.
  • Answer ALS Foundation: ALS-focused research initiative providing patient-derived data and bio samples to researchers. Comparable ALS-specific mission with emphasis on accelerating precision medicine and clinical research infrastructure.
  • ALS Therapy Development Institute: Boston-based biotech nonprofit dedicated to ALS drug discovery and preclinical research. Comparable ALS-specific mission with research funding focus, but distinct drug-development orientation.
  • Les Turner ALS Foundation: Chicago-based ALS nonprofit providing support services, research funding, and advocacy since 1977. A Cures Collective steering committee member with overlapping patient support and ALS advocacy mission.

Emerging players

  • Target ALS: ALS-focused nonprofit funding collaborative research and translational drug development. Comparable disease-specific research funding focus, but more narrowly oriented to academic-industry collaboration.
  • EveryLife Foundation for Rare Diseases: Rare disease policy advocacy organization focused on accelerating FDA review of therapies. Comparable federal legislative advocacy orientation for underserved disease populations, including ALS-relevant policy work.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

I AM ALS. social profiles

Digital presence

I AM ALS. financial estimates

Financial estimate

Revenue estimate

Valuation estimate

I AM ALS. leadership team

Management profile

Number of profiles

Profiles23 records

I AM ALS. funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

I AM ALS. M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about I AM ALS.

What does I AM ALS. do?

I AM ALS is a patient-led nonprofit organization that provides free, personalized support services to people living with ALS, caregivers, veterans, and bereaved families — including one-on-one ALS Support Specialists, peer mentorship, virtual support groups, and educational programs. It also runs federal advocacy campaigns (Push for Progress and ACT for ALS reauthorization) to expand research funding and treatment access, and coordinates the Cures Collective coalition of 50+ neurodegenerative disease organizations.

Is I AM ALS. a public or private company?

I AM ALS. is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was I AM ALS. founded?

I AM ALS. was founded in 2019. It employs 51 to 100 people.

Where is I AM ALS. based?

I AM ALS. is headquartered in Washington, United States, in the North America region.

How does I AM ALS. make money?

Five revenue lines are on record. Individual Donations are the primary driver. The others are peer-to-Peer Fundraising, employer Matching, stock and Cryptocurrency Donations and foundation and Corporate Grants.

Who are I AM ALS.'s main competitors?

Broad incumbents on record are National Organization for Rare Disorders (NORD), ALS Association and Muscular Dystrophy Association (MDA). Direct peers are Michael J. Fox Foundation for Parkinson's Research, BrightFocus Foundation, Answer ALS Foundation, ALS Therapy Development Institute and Les Turner ALS Foundation. Emerging players are Target ALS and EveryLife Foundation for Rare Diseases.

Does I AM ALS. have an API?

No public API is recorded for I AM ALS..

What industry is I AM ALS. in?

I AM ALS.'s product category is Nonprofit Patient Advocacy and ALS Support Services. Its primary akta.pro industry code is BPAGACAA, Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS). Its NAICS code is 8139 and its SIC code is 8600.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireI AM ALS COMMUNITY CELEBRATES AS ACT FOR ALS BECOMES LAW AND MAKES HISTORYThe President signed the ACT for ALS reauthorization bill into law, renewing the program for five more years. The law includes up to $500 million in additional funding and therapy access, following Senate approval by unanimous consent. I AM ALS advocates credited the passage to their grassroots campaign.PR NewswireTANEA "REBEL" BROOKS STEPS UP HER LEADERSHIP ROLE, JOINING I AM ALS AS HONORARY BOARD MEMBER FOLLOWING SENATE PASSAGE OF ACT FOR ALSTanea "Rebel" Brooks was named the first Honorary Board Member of I AM ALS after the Senate unanimously passed the ACT for ALS reauthorization bill. The bill extends ALS programs through fiscal year 2031, adding up to $500 million in funding. Brooks will continue her advocacy to raise awareness and mobilize fans.SiAEW Star Tanea 'Rebel' Brooks Joins I AM ALS as Honorary Board MemberTanea "Rebel" Brooks was named the first honorary board member of I AM ALS, the largest patient-led ALS advocacy movement. The appointment follows the U.S. Senate's unanimous passage of the ACT for ALS reauthorization bill on September 28, 2026. Brooks will continue her advocacy to raise awareness and funds for ALS treatment.PR NewswireSimplicity's Protected Tomorrows®and I AM ALS Partner to Launch Financial Wellness Program for the ALS CommunityI AM ALS and Protected Tomorrows launched the ALS Financial Wellness Program, a virtual financial planning and counseling service for ALS families, starting October 13, 2026. The program addresses financial burdens, with research estimating $1.43 million in care costs and 68% of patients citing financial burden as a top challenge.PR NewswireI AM ALS COMMUNITY POWERS HISTORIC REAUTHORIZATION OF ACT FOR ALSThe Senate passed the ACT for ALS reauthorization by unanimous consent on September 28, 2026, with the bill awaiting presidential signature. The law, which has invested hundreds of millions in research and provided investigational therapy to over 800 patients, will receive up to $500 million in additional funding for five more years.AdvfnI AM ALS Movement Collects More Than 20,100 Petition Signatures Urging Congress to "Finish the Job" and Reauthorize ACT for ALS Before September 30 DeadlineI AM ALS collected over 20,100 signatures on a petition urging Congress to reauthorize the ACT for ALS law before its September 30 expiration. The petition, signed in four days, calls on Senate HELP and House Energy and Commerce committees to avoid program disruptions. I AM ALS continues the campaign and encourages constituents to contact their representatives.WikipediaRebel Heart (professional wrestling): Difference between revisionsProfessional wrestler Tanea Brooks, known as Rebel, was diagnosed with primary pulmonary lymphoma in November 2025 and subsequently with ALS in May 2026 while undergoing cancer treatment. All Elite Wrestling announced on July 27, 2026, that it would present a television special titled 'Rebel Heart' at Akins Ford Arena in Athens, Georgia on September 9, 2026, with event profits donated to I AM ALS and Team Gleason. Multiple AEW wrestlers participated in ALS ice bucket challenges throughout July and August 2026 to show support for Brooks.WikipediaRebel Heart (professional wrestling): Difference between revisionsProfessional wrestler Tanea Brooks (Rebel), absent from AEW since 2022, was diagnosed with primary pulmonary lymphoma in November 2025 and subsequently with ALS in May 2026 while undergoing cancer treatment. All Elite Wrestling announced a television special titled 'Rebel Heart' scheduled for September 9, 2026 at Akins Ford Arena in Athens, Georgia, with event profits donated to I AM ALS and Team Gleason, two organizations dedicated to ALS awareness and patient support. Multiple AEW wrestlers and performers participated in ice bucket challenges throughout July and August 2026 to raise awareness and show support for Brooks.PeoplemagEric Dane Called ALS 'So Horrible' in Final Public Appearance in I AM ALS Virtual PanelActor Eric Dane died at age 53 on February 19, ten months after publicly revealing his diagnosis with amyotrophic lateral sclerosis (ALS). In his final public appearance in December 2025, he participated in a virtual panel for I AM ALS and Synapticure to advocate for research and raise awareness about the disease. His family confirmed his passing, describing him as a passionate advocate who remained buoyant despite the challenges of his condition.TheWrapEric Dane Says He Maintains a 'Buoyant' Attitude After ALS Diagnosis Despite Having 'No Reason' to Be HappyActor Eric Dane discussed his ALS diagnosis and his role as an ambassador for the nonprofit I AM ALS during a Giving Tuesday virtual conversation. He highlighted the bureaucratic hurdles in current ALS treatments and emphasized his commitment to raising awareness and improving the landscape for patients.